NOVARA MARK DAVID (EVP & CHIEF COMMERCIAL OFFICER) sold 0.5% of their position (187.00 shares) of TANDEM DIABETES CARE INC on the open market
Open‑market sale worth $4.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/18/2026ACC: 0001438133-26-000023
Officer· EVP & CHIEF COMMERCIAL OFFICER
Since Mar 2026
-5.73K
Net shares
Net seller
$123.9K
Total sold
1
Open market trades
0B · 1S
4
Total transactions
7.41K acquired · 13.14K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+7.41K
Price / share
—
Trade value
—
% of position
20.6%
3/16/2026
35.97K→43.38K
Common Stock
Direct
Shares
−5.54K
Price / share
$21.59
Trade value
$119.61K
% of position
12.8%
3/16/2026
43.38K→37.84K
Common Stock
Direct
Shares
−187.00
Price / share
$23.05
Trade value
$4.31K
% of position
0.5%
3/17/2026
37.84K→37.66K
Total
Net shares
+1.69K
Net value
-$123.92K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/16/2026 | M · Option Exercise | +7.41K | — | — | 20.6% | 35.97K | 43.38K |
| Common Stock Direct | 3/16/2026 | F · Tax Withholding | −5.54K | $21.59 | $119.61K | 12.8% | 43.38K | 37.84K |
| Common Stock Direct | 3/17/2026 | S · Sale | −187.00 | $23.05 | $4.31K | 0.5% | 37.84K | 37.66K |
| Total | +1.69K | -$123.92K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
7.41K shares
Shares
−7.41K
Strike price
Held after
22.24K
Exercisable
—
3/16/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock7.41K shares | 3/16/2026 | M · Option Exercise | −7.41K | — | 22.24K |